Cytosol currently has three proprietary products with new drug application approvals: TriCitrasol, noClot-50 and Rejuvesol.
Read the Biomet news release.
Read other coverage on Biomet.
-Biomet’s Indiana Facility to Expand
-Biomet Sports Medicine Mobile Learning Center to Provide Product Demonstration and Education
-Biomet Announces 4Q FY 2010 Financial Results
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
